Disc Medicine, Inc. Income Statement
IRON / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| SG&A Expense | $65.4M | $33.0M | $21.9M | $14.0M | $5.8M | $5.9M |
| R&D Expense | $170.6M | $96.7M | $69.3M | $33.4M | $25.2M | $28.2M |
| Operating Income | -$236.0M | -$129.7M | -$91.1M | -$47.5M | -$30.9M | -$34.0M |
| Interest Expense | - | - | - | - | $2.2M | $6.8M |
| Income Tax | $361.0K | $355.0K | $99.0K | $0 | - | - |
| Net Income | -$212.2M | -$109.4M | -$76.4M | -$46.8M | -$36.0M | -$40.8M |
| EPS (Basic) | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | - |
| EPS (Diluted) | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | - |
| Shares Outstanding | 35.3M | 27.6M | 22.3M | 1.0M | 878.4K | 15.1M |